Clinical Trial Update: Study of XL228 in Subjects With Chronic Myeloid Leukemia or Philadelphia-Chromosome-Positive Acute Lymphocytic Leukemia [Phase 1]

View source ↗

Summary

Clinical trial update for XL228 in chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia; the Phase 1 study has terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia
• Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Drugs mentioned

• XL228 (XL228)

Snippet

Sponsor: Exelixis | Conditions: Chronic Myeloid Leukemia, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive | Phase 1 | Status: TERMINATED